Venus Concept Announces Shareholder And Management Changes: Sets The Stage For Continued Strong Growth

Share Article

Leader in global aesthetics market announces increase in equity positions by Longitude Capital Management and Aperture Venture Partners.

Venus Concept

We believe that the Company’s differentiated product line, proven distribution model and strong management team will continue to drive success for the Company in this large target market.

Venus Concept, LTD a leader in the global aesthetics market is pleased to announce that Longitude Capital Management Co., LLC and Aperture Venture Partners LLC, have purchased equity positions in Venus Concept through the purchase of shares directly from the company co-founders, Oded and Orit Ron Edoute. Longitude had previously invested directly in the Company in May 2014.

In related management changes, Oded Ron Edoute has stepped down as Chairman of the Board, but will continue with the Company, focusing on the development of the Chinese and Hong Kong markets. Orit Ron Edoute has transitioned out of the Company. In addition, the Company is pleased to announce the following additions to the current management team: Ms. Tal Bresler as Vice President of Regulatory Affairs and Quality Control, and Tal Nachlieli MD as Vice President of Medical Affairs.

Juliet Tammenoms Bakker, Managing Director, Longitude Capital said, “We are very pleased to have increased our ownership position in Venus Concept. We believe that the Company’s differentiated product line, proven distribution model and strong management team will continue to drive success for the Company in this large target market.” Anthony Natale, M.D., General Partner at Aperture, said, “We believe that Venus Concept provides unmatched service to aesthetic physicians and best in class solutions for their patients. We are excited to participate in this transaction to support the outstanding management team as they continue to build an industry-leading organization.”

Domenic Serafino, CEO and Co-Founder of Venus Concept, will assume the role of Chairman, and said, “This investment is transformative for the Company as approximately 40% of the Company is now owned by three top tier U.S. based investors – Longitude, Aperture and Deerfield Capital Management LLC. Their ownership clearly endorses our company and our strategy. I would also like to acknowledge the important contributions made to the Company by Orit Ron Edoute. We are grateful for her efforts and wish her all the best. We are also very pleased that Oded Ron Edoute will continue to work with the Company in the Far East. Also, the key management additions demonstrate our ability to attract outstanding people who want to work in a dynamic company.”

About Venus Concept
Venus Concept is a worldwide leader providing differentiated comprehensive aesthetic solutions combined with dedicated customer service. Our products and services are delivered through a partnership model with physicians to produce best in class patient outcomes and satisfaction.

About Longitude Capital
Longitude Capital is a private investment firm that focuses on venture growth investments in drug development and medical technology. Longitude Capital has over $700 million in assets under management.

About Aperture Venture Partners
Aperture Venture Partners is a healthcare-focused venture capital group committed to working with exceptional entrepreneurs to build innovative companies in the medical device, biopharmaceutical and diagnostic sectors. Aperture's principals have deep industry knowledge and a track record of success in helping outstanding companies realize their potential.

For more information on this press release please contact Domenic Serafino (dom@venusconcept.com) or call 1-888-907-0115, ext. 101.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Franklin Tello
Venus Concept
+1 (888) 907-0115 Ext: 139
Email >
@VenusConcept
Follow >
Venus Concept
Like >
Visit website